Benitec Biopharma Inc. (BNTC)
Company Info
| ISIN | US08205P1003 |
|---|---|
| CUSIP | 08205P100 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $18.12M |
|---|---|
| EPS | -$236.13 |
| Revenue (TTM) | $61.00K |
| Gross Profit (TTM) | $75.00K |
| EBITDA (TTM) | -$21.60M |
| Year Range | $1.86 - $9.01 |
| Target Price | $10.00 |
| Short % | 0.57% |
| Short Ratio | 0.55 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Benitec Biopharma Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Benitec Biopharma Inc. had a return of 108.05% year-to-date (YTD) and 79.76% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 108.05% | 6.33% |
| 1 month | 35.48% | -2.81% |
| 6 months | 90.91% | 21.13% |
| 1 year | 79.76% | 24.56% |
| 5 years (annualized) | -57.82% | 11.55% |
| 10 years (annualized) | N/A | 10.55% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -13.00% | 72.60% | 8.25% | |||||||||
| 2023 | 2.43% | 19.47% | -11.91% | 1.57% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Benitec Biopharma Inc.(BNTC)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Benitec Biopharma Inc. (BNTC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Benitec Biopharma Inc. granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.77 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.20% |
Monthly Dividends
The table displays the monthly dividend distributions for Benitec Biopharma Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | |||||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2018 | $0.77 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Benitec Biopharma Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Benitec Biopharma Inc. was 99.97%, occurring on Aug 8, 2023. The portfolio has not yet recovered.
The current Benitec Biopharma Inc. drawdown is 99.88%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.97% | Jun 26, 2014 | 2216 | Aug 8, 2023 | — | — | — |
Volatility
Volatility Chart
The current Benitec Biopharma Inc. volatility is 41.12%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |